PERITONITIS DUE TO AN INTRAUTERINE CONTRACEPTIVE DEVICE
Keywords:
Peritonitisis, sexual intercourse, inflammation, “Queen Geraldine” Hospital, Tirana, infectious and inflammatory disorder of the female genital tract, etc.Abstract
Objectives: Reporting peritonitis as a complication to a patient holding copper IUD for 9 years, this ended in hysterectomy.
Method: Reporting the case of a patient who was hospitalized and operated in gynecology at “Queen Geraldine” Hospital, Tirana.
Results: Patient with high temperature of 39.5˚C, pain at the end of the abdomen with moderate intensity, with no accompanying illnesses. After ambulatory treatment with antipyretics, the complaints persisted. In this situation she was addressed to the gynecological service, “Queen Geraldine” Hospital, Tirana. In the history of the patient, she has had around 9 years since she has placed copper IUD and repeated unrecognized vaginal infections. The ultrasound examination showed: uterus with size 86 x 53 x 56mm. The IUD was found in the cavity in a normal position, an admixed mass with a size of 66 x 55 mm of dishomogeneous
content. At the Douglas level, stretching to the right adjective, a hypoecogeneous piriform mass is found in favor of a pyosalpingitis. In the hemogram obtained a leukocytosis of 22.37 x 10 *9/L, granulocytes 20.68 x 10 * 9/L, HGB 9.4 g/dl. In the vaginal examination, the uterus was included with a massive conglomerate occupying the whole of Douglas and tamponized by intestines, dolent, with fluctuation. Affiliates included in this conglomerate. Parameters sore, infiltrated. The patient underwent antibiotic therapy for 7 days, improving the situation of complaints and preparing for intervention.
Conclusions: The patient underwent supravaginal hysterectomy and bilateral salpingo-oophorectomy, a peritoneal wash, after the peritoneal generalization was found. Postoperative deafness of the patient, with early placement of peristalsis and significant improvement of the clinical staff. Antibiotic prophylaxis at the time of IUD placement, patient explanation for its complications, and correct tracking over the years are important in preventing these severe situations. It is also worth emphasizing the importance of accurate diagnosis and timely intervention in chronic SIP or generalized peritonitis.
Recommendations: Proper timely screening and treatment of vaginal infections in IUD carriers prevents pelvic inflammatory disease and consequently severe peritoneal complications.
References
American Phamily Physician, Intrauterine Devices: An Update 2019.
Clinical Gynecology 2015.
Chi 1-C, Potts M, Wazak C: The IUD still has an important place in family planning. IPPF Medical Bulletin 20:2, 1986 2. Tietze C, Lewit S: Evaluation of intrauterine devices: ninth progress report of the Cooperative Statistical Program. Stud FamPlann 55:1
World Health Organization: Intra-uterine devices
Advisory Committee on Obstetrics and Gynecology: Report on intrauterine contraceptive devices. Washington, DC, US Food and Drug Administration.
American College of Obstetricians and Gynecologists: The intrauterine device. ACOG Tech Bull No. 10.
Wright NH, Laemmle P: Acute pelvic inflammatory disease in an indigent population.
Targum SD, Wright NH: Association of the intrauterine device and pelvic inflammatory disease: a retrospective pilot study. Am J Epidemiol 100: 262, 1974.
Washington AE, Cates W, Zaidi AA: Hospitalizations for pelvic inflammatory disease.
Adler MW: Trends for gonorrhea and pelvic inflammatory disease in England and Wales and for gonorrhea in a defined population. Am J Obstet Gynecol138:901.
St. John RK, Jones OG, Blount JH, Zaidi AA: Pelvic inflammatory disease in the United States: epidemiology and trends among hospitalized women. Sex Transm Dis 8:62, 1981 28. Rosenfeld DL, Seidman SM, Bronson RA, Scholl GM: Unsuspected chronic pelvic inflammatory disease in the infertile female. Fertil Steril 39: 44.
Eschenbach DA, Harnisch JP, Holmes KK: Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors. Am J Obstet Gynecol128:838, 1977 38. Flesh G, Weiner JM, Corlett RC, Boice C, Mishell DR Jr, Wolf RM: The intrauterine contraceptive device and acute salpingitis, a multifactor analysis. Am J ObstetGynecol 135: 102.
Maqueo M, Calderon JJ, Guerra A: Salpingitis associated with the presence of nonmedicated IUDs. Contraception 19: 539.
Kaufman DW, Shapiro S, Rosenberg L, Monson RR, Miettinen OS, Stolley PD, Slone D: Intrauterine contraceptive device use and pelvic inflammatory disease. Am J Obstet Gynecol 136: 159.
Burkman RJ: Intrauterine device use and the risk of pelvic inflammatory disease. Am J Obstet Gynecol36:452, 44. Paavonen J, Vesterinem E: Intrauterine contraceptive device use in patients with acute salpingitis. Contraception 22: 107. Effect of different types of intrauterine devices on the risk of pelvic inflammatory disease. JAMA 250:759
Wolmer-Hanssen P, Svensson L, Mardh P-A, Westrom L: Laparoscopic findings and contraceptive use in women with signs and symptoms suggestive of acute salpingitis. ObstetGynecol 66:233, Guderian AM, Trobough GE: Residues of pelvic inflammatory disease in intrauterine device users: a result of the intrauterine device or Chlamydia trachomatis infection? Am J Obstet Gynecol 154: 497.
